Microbicide Innovation Program (MIP IV) (R21/R33)
The summary for the Microbicide Innovation Program (MIP IV) (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Microbicide Innovation Program (MIP IV) (R21/R33): -Purpose. This FOA, The Microbicide Innovation Program (MIP IV), issued by NIAID, NIMH, and supported by the Office of Research in Women's Health (ORWH) in the Office of the Director, National Institutes of Health, solicits Research Project Grant (R21/R33) applications in the field of topical microbicides to advance: -Mechanism of Support. This FOA will utilize the NIH R21/R33 Phased Innovation Award to support innovative exploratory and developmental research. Under the R21 phase, research is initiated and carried out through a milestone-driven process to establish the feasibility of new microbicides, microbicide strategies and support technologies. The R33 phase then provides the support required to translate the innovation discoveries into the preclinical/clinical development pipeline. -Funds Available and Anticipated Number of Awards. The NIAID intends to commit approximately $2,000,000 in FY 2009 to fund 10 to 15 grants. Funding will be based on scientific and technical merit, program priorities, and availability of funds. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.
|Federal Grant Title:||Microbicide Innovation Program (MIP IV) (R21/R33)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-AI-08-016|
|Type of Funding:||Grant|
|CFDA Descriptions:||Mental Health Research Grants 93.855 Allergy, Immunology and Transplantation Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Jul 25, 2008|
|Posted Date:||Apr 16, 2008|
|Creation Date:||Apr 16, 2008|
|Archive Date:||Aug 25, 2008|
|Total Program Funding:||$2,000,000|
|Maximum Federal Grant Award:||$200,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||93.856 -- Microbiology and Infectious Diseases Research|
- Applicants Eligible for this Grant
- Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Independent school districts Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Special district governments Native American tribal governments (Federally recognized) County governments
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...